4//SEC Filing
Oien Jessica 4
Accession 0000950170-24-099307
CIK 0001782303other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:11 PM ET
Size
33.6 KB
Accession
0000950170-24-099307
Insider Transaction Report
Form 4
Oien Jessica
See Remarks
Transactions
- Disposition to Issuer
Stock Option
2024-08-19−29,148→ 0 totalExercise: $4.10Exp: 2031-12-05→ Common Stock (29,148 underlying) - Disposition to Issuer
Stock Option
2024-08-19−26,090→ 0 totalExercise: $8.19Exp: 2034-02-14→ Common Stock (26,090 underlying) - Disposition to Issuer
Stock Option
2024-08-19−32,051→ 0 totalExercise: $4.10Exp: 2031-09-14→ Common Stock (32,051 underlying) - Disposition to Issuer
Stock Option
2024-08-19−10,200→ 0 totalExercise: $4.10Exp: 2032-12-12→ Common Stock (10,200 underlying) - Award
Stock Option
2024-08-19+42,051→ 42,051 totalExercise: $3.56Exp: 2033-06-12→ Common Stock (42,051 underlying) - Award
Stock Option
2024-08-19+26,090→ 26,090 totalExercise: $3.56Exp: 2034-02-14→ Common Stock (26,090 underlying) - Award
Stock Option
2024-08-19+10,200→ 10,200 totalExercise: $3.56Exp: 2032-12-12→ Common Stock (10,200 underlying) - Disposition to Issuer
Stock Option
2024-08-19−42,051→ 0 totalExercise: $4.10Exp: 2033-06-12→ Common Stock (42,051 underlying) - Disposition to Issuer
Stock Option
2024-08-19−35,897→ 0 totalExercise: $4.49Exp: 2033-12-12→ Common Stock (35,897 underlying) - Disposition to Issuer
Stock Option
2024-08-19−16,234→ 0 totalExercise: $16.00Exp: 2034-03-26→ Common Stock (16,234 underlying) - Award
Stock Option
2024-08-19+32,051→ 32,051 totalExercise: $3.56Exp: 2031-09-14→ Common Stock (32,051 underlying) - Award
Stock Option
2024-08-19+29,148→ 29,148 totalExercise: $3.56Exp: 2031-12-05→ Common Stock (29,148 underlying) - Award
Stock Option
2024-08-19+35,897→ 35,897 totalExercise: $3.56Exp: 2033-12-12→ Common Stock (35,897 underlying) - Award
Stock Option
2024-08-19+16,234→ 16,234 totalExercise: $3.56Exp: 2034-03-26→ Common Stock (16,234 underlying)
Footnotes (9)
- [F1]The stock option vested as to 25% of the underlying shares on August 30, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.
- [F2]On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.
- [F3]The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.
- [F4]The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2023.
- [F5]The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.
- [F6]The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.
- [F7]The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.
- [F8]The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.
- [F9]The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.
Documents
Issuer
Boundless Bio, Inc.
CIK 0001782303
Entity typeother
Related Parties
1- filerCIK 0001760712
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 7:11 PM ET
- Size
- 33.6 KB